Apyx Medical Corp (APYX)
NASDAQHealth CareMedical - SpecialtiesSnapshot 2026-09-04
$3.05-0.33%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - SpecialtiesSnapshot 2026-09-04
QuarterlyIQ Insights · APYX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 58.4 | 52.8 | 48.1 | 52.3 | 44.5 | 48.5 | 27.7 | 28.2 | 16.7 | 10.2 | 8.8 | 29.5 | 27.7 | 27.7 | 27.7 | 25.4 |
| Total Revenues | — | — | — | — | — | — | — | — | 16.7 | 10.2 | 8.8 | 29.5 | 27.7 | 27.7 | 27.7 | 25.4 |
| Cost of Revenues | 21.3 | 19.8 | 18.7 | 18.6 | 15.4 | 14.9 | 10.2 | 9.1 | 5.8 | 3.3 | 3.7 | 17.0 | 18.7 | 16.3 | 16.3 | 14.7 |
| Gross Profit | 37.1 | 33.0 | 29.4 | 33.8 | 29.1 | 33.6 | 17.5 | 19.1 | 10.8 | 7.0 | 5.1 | 12.6 | 9.0 | 11.3 | 11.3 | 10.7 |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 16.9 | 15.8 | 18.9 | 22.2 | 20.5 | 18.6 | 11.7 | 13.7 | 9.4 | 8.7 | 6.2 | 8.4 | 6.7 | 4.3 | 4.3 | 4.3 |
| R&D Expenses | 3.3 | 3.4 | 5.1 | 5.4 | 4.5 | 4.3 | 3.9 | 3.7 | 2.5 | 1.9 | 1.0 | 2.2 | 1.4 | 1.3 | 1.3 | 1.2 |
| Other Operating Expenses, Total | 0.1 | 0.1 | (0.2) | 0.6 | 0.5 | (0.4) | 0.5 | (0.4) | (0.9) | — | — | — | — | — | — | — |
| Operating Income | (3.5) | (6.4) | (18.8) | (17.3) | (23.6) | (14.4) | (20.1) | (20.9) | (14.3) | (13.9) | (11.4) | (7.0) | (5.8) | 1.0 | 1.0 | (0.0) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | 5.6 | 5.9 | 2.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | — | — | — | — | — | — | — |
| Interest & Investment Income | 1.0 | 1.1 | 1.6 | 0.9 | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Interest Expenses | — | — | — | 1.6 | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Non-Operating Income / Expenses | (4.4) | (4.4) | (4.5) | (4.0) | — | — | — | — | — | — | — | — | — | — | — | — |
| Asset Writedown | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 |
| EBT, Incl. Unusual Items | (8.0) | (10.8) | (23.3) | (21.3) | (22.9) | (14.8) | (19.4) | (19.8) | (14.7) | (13.8) | (11.5) | (5.3) | (13.3) | 0.8 | 0.8 | 0.0 |
| Income Tax Expense | 0.4 | 0.3 | 0.3 | (2.4) | 0.4 | 0.4 | (7.5) | (0.1) | (3.9) | (0.2) | 0.1 | 0.0 | 4.0 | 0.2 | 0.2 | 0.1 |
| Net Income | ||||||||||||||||
| Minority Interest | 0.2 | 0.1 | (0.1) | (0.1) | (0.1) | (0.0) | (0.0) | — | — | — | — | — | — | — | — | — |
| Net Income | (8.6) | (11.2) | (23.5) | (18.7) | (23.2) | (15.2) | (11.9) | (19.7) | 62.7 | (5.1) | (11.6) | (5.4) | (17.3) | 0.6 | 0.6 | 0.1 |
| Per Share | ||||||||||||||||
| Basic EPS | (0.20) | (0.27) | (0.66) | (0.54) | (0.67) | (0.44) | (0.35) | (0.58) | 1.89 | (0.16) | (0.14) | 0.34 | (1.03) | 0.04 | 0.04 | 0.01 |
| Diluted EPS | — | — | — | (0.54) | (0.67) | (0.44) | (0.35) | (0.58) | 1.83 | (0.17) | (0.15) | 0.24 | (1.03) | 0.03 | 0.03 | 0.01 |
| Basic Weighted Avg Shares | 43.9 | 41.1 | 35.5 | 34.6 | 34.5 | 34.3 | 34.2 | 34.1 | 33.2 | 31.4 | 27.4 | 24.3 | 17.8 | 0.0 | 0.0 | 0.0 |
| Diluted Weighted Avg Shares | — | — | — | 34.6 | 34.5 | 34.3 | 34.2 | 34.1 | 34.4 | 31.4 | 27.4 | 27.7 | 17.8 | 0.0 | 0.0 | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | (5.8) | (18.2) | (16.6) | (22.7) | (13.5) | (19.2) | (20.1) | (13.6) | (13.2) | (10.7) | (6.2) | (5.7) | 1.9 | 1.8 | 0.7 |
| EBIT | (3.5) | (6.4) | (18.8) | (17.3) | (23.6) | (14.4) | (20.1) | (20.9) | (14.3) | (13.9) | (11.4) | (7.0) | (5.8) | 1.0 | 1.0 | (0.0) |
| Effective Tax Rate | -5.5% | — | — | 11.4% | -1.6% | -2.6% | 38.7% | 0.7% | 26.6% | 1.1% | -0.6% | -0.5% | -30.1% | 26.0% | 26.0% | 240.6% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.